W. Pache

9 papers receiving 440 citations

Peers

W. Pache
Comparison fields: 5 of 84
  • Pharmacology 163
  • Biotechnology 57
  • Molecular Medicine 22
  • Organic Chemistry 110
  • Molecular Biology 264
Replace Peter P. Regna with:
Peter P. Regna United States
James W. Chamberlin United States
W. Voser Germany
L. H. Conover United Kingdom
H Zähner Germany
R. Corbaz Switzerland
John P. Dirlam United States
I. A. Solomons United States
L. Neipp Switzerland
John W. Corcoran United States
W. Pache relative to Peter P. Regna United States Peter P. Regna's profile →
Citations per field
00.5×
Peter P. Regna · 1×
Citations per year

Countries citing papers authored by W. Pache

Since Specialization
Citations

This map shows the geographic impact of W. Pache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Pache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Pache more than expected).

Fields of papers citing papers by W. Pache

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Pache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Pache. The network helps show where W. Pache may publish in the future.

Co-authorship network

The 8 scholars most cited alongside W. Pache, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Pache Line = papers co-authored together W. Pache links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 19786
2 197233
3 197276
4
Metabolic products of microorganisms. 77. Studies on the mechanism of action of boromycin.
1969236
5 196933
6
[Metabolic products of microorganisms. 76. Binding of antibiotics to lipoprotein].
19695
7 196921
8 196963
9 19699

About W. Pache

W. Pache is a scholar working on Filtration and Separation, Molecular Medicine, Pharmacology, Pharmaceutical Science and Electrochemistry, having authored 9 papers that have together received 482 indexed citations. Recurring topics across this work include Enzyme Catalysis and Immobilization (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Biopolymer Synthesis and Applications (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Polyamine Metabolism and Applications (2 papers), Antibiotic Resistance in Bacteria (2 papers), Lipid Membrane Structure and Behavior (2 papers) and Steroid Chemistry and Biochemistry (2 papers). The work is most often cited by research in Pharmacology (163 citations), Biotechnology (57 citations), Molecular Medicine (22 citations), Organic Chemistry (110 citations) and Molecular Biology (264 citations). W. Pache has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Hans Zähner, D. Chapman, W. Keller‐Schierlein, H. Z�hner, H Zähner, W. Simon, H.‐K. Wipf and P. Jordan. Their work appears in journals such as Archives of Microbiology, Biochimica et Biophysica Acta (BBA) - Biomembranes, Biochemical and Biophysical Research Communications, Applied Microbiology and Biotechnology and Helvetica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026